Cross-sectional and Questionnaire Study for Leg Lymphedema
The Cross-sectional and Questionnaire Study of Pelvic and Lower Extremity Lymphedema After Treatment of Gynecological Disease
2 other identifiers
observational
333
0 countries
N/A
Brief Summary
The purpose of this study is to identify the incidence,feature,clinical significance for leg lymphedema after gynecologic cancer treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2012
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 31, 2013
CompletedFirst Posted
Study publicly available on registry
February 24, 2014
CompletedFebruary 24, 2014
February 1, 2014
5 months
May 31, 2013
February 19, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gynecologic Cancer Lymphedema Questionnaire
There are no more follow up except one time telephone interview.
The study outcome measure will be assessed by telephone interview , one time.
Study Arms (3)
early ovarian cancer group
locally advanced cervical cancer group
primary endometrial cancer group
Eligibility Criteria
the patient who gynecologic cancer treatment at National Cancer Center (2001\~2011)
You may qualify if:
- the patient who gynecologic cancer treatment at National Cancer Center , Korea(2001\~2011)
- no active cancer treatment at the moment
- available telephone communication
You may not qualify if:
- \<More information by cancer type\>
- \*early ovarian cancer (FIGO stage I and II) at National Cancer Center, Korea who underwent cytoreductive and staging surgery between January 2001 and December 2010
- locally advanced cervical cancer group patients with locally advanced cervical cancer who treatment at National Cancer Center, Korea between October 2001 and July 2007. Of 222 patients with locally advanced cervical cancer, 74 patients were underwent pretreatment laparoscopic surgical staging and 148 patients received radiotherapy . Women with locally advanced cervical cancer, no active treatment at survey, available telephone communication, and ability and willingness to provide verbal informed consent were considered to include in the current study.
- primary endometrial cancer group patients with endometrial cancer who underwent surgery, no active treatment at survey, available telephone communication, and ability and willingness to provide verbal informed consent were considered to include in the current study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Myong Cheol Lim, MD,PhD
National Cancer Center, Korea
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Faculty, Center for Uterine Cancer
Study Record Dates
First Submitted
May 31, 2013
First Posted
February 24, 2014
Study Start
June 1, 2012
Primary Completion
November 1, 2012
Study Completion
November 1, 2012
Last Updated
February 24, 2014
Record last verified: 2014-02